Kenichi Inoue Selected Research

Neoplasm Metastasis (Metastasis)

1/2021	Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer.
6/2018	Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators.
12/2016	Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.
1/2016	Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance.
6/2013	Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.
7/2011	Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.
1/2010	Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.
8/2009	Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer.
1/2007	Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenichi Inoue Research Topics

Disease

80	Breast Neoplasms (Breast Cancer) 11/2021 - 01/2002
33	Neoplasms (Cancer) 09/2021 - 01/2006
11	Neutropenia 09/2021 - 01/2006
9	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2007
7	Diarrhea 09/2021 - 01/2013
7	Nausea 02/2019 - 02/2009
6	Disease Progression 11/2021 - 01/2010
6	Triple Negative Breast Neoplasms 01/2020 - 03/2011
6	Vomiting 02/2019 - 02/2009
5	Leukopenia 09/2021 - 01/2006
3	Peripheral Nervous System Diseases (PNS Diseases) 10/2020 - 08/2013
3	Pain (Aches) 01/2018 - 07/2011
3	Fatigue 09/2017 - 02/2016
2	Lung Neoplasms (Lung Cancer) 01/2020 - 02/2016
2	Hyperglycemia 01/2019 - 09/2012
2	Alopecia (Baldness) 06/2018 - 12/2015
2	Febrile Neutropenia 08/2017 - 10/2006
2	Constipation 01/2013 - 02/2009
2	Body Weight (Weight, Body) 09/2012 - 10/2009
2	Margins of Excision 03/2010 - 08/2009
2	Ductal Carcinoma 01/2007 - 07/2003
1	Injection Site Reaction 01/2022
1	Vascular Remodeling 07/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Stomatitis 12/2019
1	Residual Neoplasm 01/2019
1	Exanthema (Rash) 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Tremor (Tremors) 01/2019

Drug/Important Bio-Agent (IBA)

19	Hormones (Hormone)IBA 11/2021 - 01/2007
18	Trastuzumab (Herceptin)FDA Link 08/2021 - 01/2006
16	Estrogen ReceptorsIBA 09/2021 - 09/2006
16	ErbB Receptors (EGF Receptor)IBA 09/2021 - 01/2010
13	Paclitaxel (Taxol)FDA LinkGeneric 08/2021 - 08/2003
9	AnthracyclinesIBA 01/2020 - 02/2009
9	Docetaxel (Taxotere)FDA Link 05/2017 - 01/2006
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2017 - 02/2009
8	Fulvestrant (Faslodex)FDA Link 11/2021 - 08/2017
8	human ERBB2 proteinIBA 10/2020 - 04/2011
7	palbociclibIBA 03/2021 - 08/2017
6	eribulin FDA Link 07/2021 - 01/2016
6	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2007
5	abemaciclibIBA 11/2021 - 09/2017
5	neratinibIBA 01/2021 - 12/2016
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2013
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2011
5	taxaneIBA 03/2017 - 03/2011
4	Lapatinib (GW572016)FDA Link 08/2021 - 05/2013
4	Palonosetron (Aloxi)FDA Link 02/2019 - 02/2009
4	Epirubicin (Ellence)FDA LinkGeneric 01/2016 - 05/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 01/2010
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2009
3	exemestane (Aromasin)FDA Link 09/2021 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2013
3	pertuzumabIBA 02/2020 - 01/2019
3	Taxoids (Taxanes)IBA 01/2020 - 03/2011
3	130-nm albumin-bound paclitaxelIBA 12/2019 - 08/2013
3	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2017
3	Aromatase InhibitorsIBA 01/2018 - 04/2011
3	Fluorouracil (Carac)FDA LinkGeneric 09/2015 - 05/2013
3	Tamoxifen FDA LinkGeneric 12/2014 - 04/2011
2	Neurokinin-1 Receptor AntagonistsIBA 01/2022 - 02/2019
2	atezolizumabIBA 01/2020 - 12/2019
2	Amino Acids FDA Link 01/2020 - 02/2016
2	Letrozole (Femara)FDA LinkGeneric 01/2020 - 03/2018
2	B7-H1 AntigenIBA 12/2019 - 11/2019
2	Messenger RNA (mRNA)IBA 06/2019 - 08/2013
2	Cyclin-Dependent Kinase 4IBA 01/2019 - 09/2017
2	Bevacizumab (Avastin)FDA Link 06/2018 - 01/2017
2	Granisetron (Kytril)FDA LinkGeneric 01/2016 - 02/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 02/2009
2	Hemoglobins (Hemoglobin)IBA 12/2015 - 10/2006
2	orantinib (SU6668)IBA 01/2014 - 08/2013
2	Oxycodone (Oxycontin)FDA LinkGeneric 08/2013 - 07/2011
2	SandIBA 10/2009 - 05/2008
2	Coloring Agents (Dyes)IBA 01/2006 - 01/2006
1	AntiemeticsIBA 01/2022
1	antineoplaston A10 (A 10)IBA 09/2021
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 02/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	titanium silicide (TS-1)IBA 01/2020
1	5'-palmitoyl cytarabine (PLAC)IBA 12/2019
1	Biological ProductsIBA 03/2019
1	netupitantIBA 02/2019
1	Cyclin D1IBA 01/2019
1	ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA 01/2019
1	AlpelisibIBA 01/2019

Therapy/Procedure

40	Therapeutics 11/2021 - 01/2002
21	Drug Therapy (Chemotherapy) 01/2022 - 10/2006
11	Neoadjuvant Therapy 01/2020 - 01/2007
7	Adjuvant Chemotherapy 01/2020 - 07/2003
4	Radiotherapy 05/2015 - 09/2006
4	Lymph Node Excision (Lymph Node Dissection) 01/2010 - 01/2007
3	Segmental Mastectomy (Lumpectomy) 06/2013 - 08/2009
2	Duration of Therapy 09/2021 - 01/2019
2	Mastectomy (Mammectomy) 05/2015 - 04/2011
1	Lasers (Laser) 06/2019
1	Drug Tapering 01/2019